In light of the 2009 influenza pandemic, discussion into control and prevention of influenza pandemics is a key topic of discussion and of research within the industry. Dr Hector Izurieta from the US FDA joined us at the World Vaccine Congress to discuss post marketing safety monitoring during an influenza pandemic. He suggests that all areas of industry to work together to monitor post marketing surveillance that go beyond just clinical trials. There needs to be a commitment and a requirement.
Watch the video to find out the answer to: what are the foreseen potential issues for pandemic H1N1 vaccines safety?
Visit our Website: http://www.terrapinn.com/2013/world-vaccine-congress-washington
Read our blog: http://blogs.terrapinn.com/vaccinenation/
Follow us on Twitter: @vaccinenation
Join our Linkedin group: http://www.linkedin.com/groups/Vaccine-Nation-1351197